Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the (a) mean and (b) median waiting time for treatment in Queen Alexandra Hospital's accident and emergency department was in each year from 2009-10.
Answered by Jane Ellison
The information is shown in the following table.
Mean and median duration (in minutes) to treatment for Portsmouth Hospitals NHS Trust accident and emergency (A&E) department, 2009-10 – 2012-13. | |||
Year | Number of attendances with a valid Duration to Treatment | Mean Duration to Treatment | Median Duration to Treatment |
2009-10 | 102,395 | 83 | 52 |
2010-11 | 108,101 | 83 | 55 |
2011-12 | 118,719 | 65 | 49 |
2012-13 | 128,728 | 70 | 48 |
Source: Hospital Episode Statistics (HES) Analysis Team at the Health and Social Care Information Centre.
Notes:
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what proportion of adults in (a) Fareham constituency, (b) Hampshire and (c) England have been diagnosed with dementia in each of the last 10 years.
Answered by Norman Lamb
Information on the number of people with dementia has been collected since 2006-07. Information is collected at National Health Service organisation level, and not constituency level. Data on the number of people with dementia in England, Hampshire Primary Care Trust, and the clinical commissioning groups (CCGs) that replaced it, are shown in the following table.
Table 1: Quality and Outcomes Framework (QOF): Patients on the dementia register and prevalence rates in England, 2006-07 to 2013-14
Year | Number of Practices1 | Sum of List Sizes1 | Sum of Dementia Register1 | Dementia Prevalence1 (percentage - based on QOF registers) |
2013-14 | 7,921 | 56,324,887 | 348,973 | 0.62 |
2012-13 | 8,020 | 56,012,096 | 318,669 | 0.57 |
2011-12 | 8,123 | 55,525,732 | 293,738 | 0.53 |
2010-11 | 8,245 | 55,169,643 | 266,697 | 0.48 |
2009-10 | 8,305 | 54,836,561 | 249,463 | 0.45 |
2008-09 | 8,229 | 54,310,660 | 232,430 | 0.43 |
2007-08 | 8,294 | 54,009,831 | 220,246 | 0.41 |
2006-07 | 8,372 | 53,681,098 | 212,794 | 0.40 |
Note:
1. Practices, practice list size and number of patients on the dementia register are based only on those GP practices that participated in QOF.
Table 2: Quality and Outcomes Framework (QOF): Patients on the dementia register and prevalence rates in the specified CCGs, 2012-13 and 2013-14
| 2012/13 | 2013/14 | ||||||
CCG Name | Number of Practices1 | Sum of List Sizes1 | Sum of Dementia Register1 | Dementia Prevalence1 (percentage - based on QOF registers) | Number of Practices1 | Sum of List Sizes1 | Sum of Dementia Register1 | Dementia Prevalence1 (percentage - based on QOF registers) |
North Hampshire
| 22 | 217,387 | 1,090 | 0.50 | 20 | 218,955 | 1,215 | 0.55 |
Fareham and Gosport
| 21 | 200,959 | 1,277 | 0.64 | 21 | 201,596 | 1,413 | 0.70 |
Portsmouth | 26 | 217,685 | 1,473 | 0.68 | 26 | 218,672 | 1,510 | 0.69 |
South Eastern Hampshire
| 28 | 208,977 | 1,568 | 0.75 | 27 | 209,540 | 1,699 | 0.81 |
Southampton | 36 | 267,765 | 1,376 | 0.51 | 35 | 269,948 | 1,467 | 0.54 |
West Hampshire
| 54 | 543,354 | 4,031 | 0.74 | 52 | 536,744 | 4,295 | 0.80 |
North East Hampshire and Farnham | 24 | 218,868 | 1,079 | 0.49 | 24 | 220,174 | 1,317 | 0.60 |
Note:
1. Practices, practice list size and number of patients on the dementia register are based only on those GP practices that participated in QOF.
Table 3: Quality and Outcomes Framework (QOF): Patients on the dementia register and prevalence rates in Hampshire Primary Care Trust, 2006-07 to 2011-12
Year | Number of Practices1 | Sum of List Sizes1 | Sum of Dementia Register1 | Dementia Prevalence1 (percentage - based on QOF registers) |
2011-12 | 146 | 1,334,272 | 8,695 | 0.65 |
2010-11 | 146 | 1,325,050 | 8,288 | 0.63 |
2009-10 | 147 | 1,316,394 | 7,998 | 0.61 |
2008-09 | 147 | 1,298,398 | 7,518 | 0.58 |
2007-08 | 146 | 1,289,145 | 7,109 | 0.55 |
2006-07 | 148 | 1,288,615 | 6,763 | 0.52 |
Note:
1. Practices, practice list size and number of patients on the dementia register are based only on those GP practices that participated in QOF.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what proportion of (a) children and (b) adults in (i) Fareham constituency, (ii) Hampshire and (iii) England were classed as (A) overweight and (B) obese in each of the last 10 years.
Answered by Jane Ellison
Data on childhood obesity are not collected by parliamentary constituency. The data in the attached table 1 and 2 are for the area of Fareham district, Hampshire County and England. The National Childhood Measurement Programme data collection began in 2006-07 and only collects data on two age groups; reception year (4-5 years) and year 6 (10-11 years).
Data on adult obesity and excess weight (overweight and obese) for Fareham district, Hampshire County and England are available from the ‘Local Health Profiles’ using data from the ‘Active People Survey’ commissioned by Sport England. The data are only available for 2012 and are presented as a total figure for males and females. This data is not collected by parliamentary constituency.
- Excess weight defined as the proportion of the adult population who are overweight or obese in 2012
Fareham district 64.8%
Hampshire County Council 65.1%
England 63.8%
- The proportion of the adult population classified as obese in 2012.
Fareham district 26.1%
Hampshire County Council 22.2%
England 23.0%
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate he has made of the cost to the public purse of supporting people with cerebral palsy.
Answered by Norman Lamb
No estimate has been made of the cost to the public purse of supporting people with cerebral palsy.
National Health Service expenditure on cerebral palsy is included in the programme budgeting category ‘neurological problems’, but cannot be separately identified. Aggregate annual NHS expenditure in this category in 2012-13, the latest period for which data is available, was £4.44 billion.
The programme budgeting data return is an analysis of commissioning expenditure by healthcare condition and care centre based on figures provided to NHS England by primary care trusts (PCTs) and PCT successor organisations. Programme budgeting data, as well as further information on how these figures were calculated, can be found on the NHS England website at the following link:
www.england.nhs.uk/resources/resources-for-ccgs/prog-budgeting/
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate he has made of the average age at which children are diagnosed with cerebral palsy.
Answered by Dan Poulter
Information is not collected centrally on the age at which children are diagnosed with cerebral palsy and therefore no estimate of the average age of diagnosis has been made.
The age at which a diagnosis of cerebral palsy is made will depend on its severity and type. In some cases it will be diagnosed at birth other cases will be picked up through screening and monitoring.
Under the Healthy Child Programme schedule, babies undergo screening and health checks or immunisations at birth, at 72 hours, at five to eight days, at six to eight weeks, 12 weeks, 16 weeks, six to eight months and 12 months, 2½ years and at school entry.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, with reference to the Answer to the hon. Member for Suffolk Coastal of 8 January 2014, Official Report, column 265W, on general practitioners: Suffolk, how much his Department spent funding each general practice in England in 2012-13; and what spending type and GP Practice code applies in each case.
Answered by Dan Poulter
The requested information is not collected centrally. The Investment in General Practice report published by the Health and Social Care Information Centre includes the investment in General Practice and the reimbursement of drugs dispensed in General Practices at national level. A copy has been placed in the Library.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much his Department spent per capita in each general practice area in Fareham constituency in the last year for which information is available.
Answered by Norman Lamb
The information is shown in the following table.
The closest geographical boundary to the question is the area covered by NHS Fareham and Gosport Clinical Commissioning Group (CCG).
Fareham and Gosport CCG General Practice spend 2013-14
General Practitioner Practice Name | Weighted List Size as at Q4 2013-14 | Total Spend 2013-14 (£) | Spend Per Capita – Weighted (£) |
Gosport Health Centre Practice | 8,638.37 | 1,336,261 | 155 |
Portchester Practice | 8,596.25 | 795,373 | 93 |
The Whiteley Surgery | 9,993.36 | 1,180,482 | 118 |
Centre Practice | 15,540.52 | 1,363,476 | 88 |
Gudgeheath Lane Surgery | 7,804.48 | 773,741 | 99 |
Jubilee Surgery | 8,259.15 | 874,108 | 106 |
Stoke Road Medical Centre | 8,752.48 | 905,412 | 103 |
Bury Road Surgery | 4,337.50 | 446,570 | 103 |
Forton Medical Centre | 9,656.23 | 1,125,220 | 117 |
Stubbington Medical Practice | 13,184.17 | 1,240,984 | 94 |
Waterside Medical Centre | 11,926.55 | 1,448,573 | 121 |
Brune Medical Centre | 8,549.08 | 1,118,871 | 131 |
Brockhurst Medical Centre | 4,345.77 | 488,803 | 112 |
Bridgemary Medical Centre | 8,503.24 | 936,475 | 110 |
Fareham Highlands Practice | 15,323.71 | 1,424,597 | 93 |
Westlands Medical Centre | 9,802.59 | 1,075,039 | 110 |
Lockswood Surgery | 10,786.16 | 1,106,611 | 103 |
Lee on the Solent Health Centre | 6,603.07 | 596,335 | 90 |
Brook Lane Surgery | 10,787.97 | 1,209,754 | 112 |
Manor Way Surgery | 4,566.91 | 444,296 | 97 |
Rowner Health Centre | 6,092.44 | 774,137 | 127 |
Totals/Average | 192,050.00 | 20,665,119 | 108 |
Source: NHS England Wessex Area Team
Note:
The average spend per capita figure of 108 is calculated as follows: Total spend 2013-14 (£20,665,119) / Total weighted list size Q4 2013-14 (192,050) = £107.60
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, who is responsible for auditing compliance with National Institute for Health and Care Excellence guidelines relating to the care of patients with diabetes.
Answered by Jane Ellison
The National Institute for Health and Care Excellence (NICE) is an independent organisation established by Government to provide national guidance and advice to improve health and social care. It has published clinical guidance and quality standards on the treatment of diabetes and its complications. The NICE Diabetes Quality Standard is clear that people with diabetes who are at risk of foot ulceration should receive regular reviews by a foot protection team in accordance with its clinical guidance. The Health and Social Care Act (2012) places a duty on NHS England to have regard to the NICE Quality Standards. Clinical commissioning groups (CCG) should also have regard to them in planning and delivering services, as part of a general duty to secure a continuous improvement in quality.
As part of the Quality Outcomes Framework (QOF), general practitioners are remunerated for assessing nerve damage and poor blood supply to the feet in people with diabetes on an annual basis. Information is collected annually both through QOF returns and through the National Diabetes Audit (NDA).
The NDA provides information of local practice against NICE guidelines and can be used by local areas to compare their own performance over time and against others, helping to drive service improvement. The latest published NDA report shows that more than 85% of all those with diabetes in England and Wales, received these checks in 2011-12.
In July 2014, NHS England will be launching the National Diabetes Footcare Audit. This is a new module of the NDA, and will provide information on the effectiveness and quality of the entire diabetes foot care pathway, including the elements delivered in primary, community and secondary care settings.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what guidance his Department has issued to GPs on the assessment and treatment of foot conditions where a patient has diabetes.
Answered by Jane Ellison
The National Institute for Health and Care Excellence (NICE) is an independent organisation established by Government to provide national guidance and advice to improve health and social care. It has published clinical guidance and quality standards on the treatment of diabetes and its complications. The NICE Diabetes Quality Standard is clear that people with diabetes who are at risk of foot ulceration should receive regular reviews by a foot protection team in accordance with its clinical guidance. The Health and Social Care Act (2012) places a duty on NHS England to have regard to the NICE Quality Standards. Clinical commissioning groups (CCG) should also have regard to them in planning and delivering services, as part of a general duty to secure a continuous improvement in quality.
As part of the Quality Outcomes Framework (QOF), general practitioners are remunerated for assessing nerve damage and poor blood supply to the feet in people with diabetes on an annual basis. Information is collected annually both through QOF returns and through the National Diabetes Audit (NDA).
The NDA provides information of local practice against NICE guidelines and can be used by local areas to compare their own performance over time and against others, helping to drive service improvement. The latest published NDA report shows that more than 85% of all those with diabetes in England and Wales, received these checks in 2011-12.
In July 2014, NHS England will be launching the National Diabetes Footcare Audit. This is a new module of the NDA, and will provide information on the effectiveness and quality of the entire diabetes foot care pathway, including the elements delivered in primary, community and secondary care settings.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment he has made of the quality of foot care provided in primary care to patients with diabetes.
Answered by Jane Ellison
The National Institute for Health and Care Excellence (NICE) is an independent organisation established by Government to provide national guidance and advice to improve health and social care. It has published clinical guidance and quality standards on the treatment of diabetes and its complications. The NICE Diabetes Quality Standard is clear that people with diabetes who are at risk of foot ulceration should receive regular reviews by a foot protection team in accordance with its clinical guidance. The Health and Social Care Act (2012) places a duty on NHS England to have regard to the NICE Quality Standards. Clinical commissioning groups (CCG) should also have regard to them in planning and delivering services, as part of a general duty to secure a continuous improvement in quality.
As part of the Quality Outcomes Framework (QOF), general practitioners are remunerated for assessing nerve damage and poor blood supply to the feet in people with diabetes on an annual basis. Information is collected annually both through QOF returns and through the National Diabetes Audit (NDA).
The NDA provides information of local practice against NICE guidelines and can be used by local areas to compare their own performance over time and against others, helping to drive service improvement. The latest published NDA report shows that more than 85% of all those with diabetes in England and Wales, received these checks in 2011-12.
In July 2014, NHS England will be launching the National Diabetes Footcare Audit. This is a new module of the NDA, and will provide information on the effectiveness and quality of the entire diabetes foot care pathway, including the elements delivered in primary, community and secondary care settings.